Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Rapport Therapeutics, Inc.

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPP
Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPP
Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPP
Rapport Therapeutics to Participate in Upcoming Investor Conferences
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPP
CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPP
Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPP
Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPP
Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPP
Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPP
Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPP
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPP
Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPP
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPP
Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPP
Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Tickers RAPP
Rapport Therapeutics Announces Pricing of Initial Public Offering
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Rapport Therapeutics Appoints Pioneering Industry Leader John Maraganore to Board of Directors
From Rapport Therapeutics, Inc.
Via Business Wire
Rapport Therapeutics Appoints Chief People Officer
From Rapport Therapeutics, Inc.
Via Business Wire
Rapport Therapeutics Appoints Terry-Ann Burrell to Board of Directors
From Rapport Therapeutics, Inc.
Via Business Wire
Rapport Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Rapport Therapeutics, Inc.
Via Business Wire
Rapport Therapeutics Appoints Chief Financial Officer
From Rapport Therapeutics, Inc.
Via Business Wire
Rapport Therapeutics Appoints Chief Operating Officer and Scientific Advisory Board Member
From Rapport Therapeutics, Inc.
Via Business Wire
Rapport Therapeutics Raises $150 Million in Series B Funding Round and Announces Key Board Appointments to Further Advance Precision Neuromedicine Platform
From Rapport Therapeutics, Inc.
Via Business Wire
Rapport Therapeutics Names Scientific Advisory Board
From Rapport Therapeutics, Inc.
Via Business Wire
Rapport Therapeutics Launches with $100 Million to Transform the Treatment of Neurological Disease through the Discovery and Development of Precision Therapies
From Rapport Therapeutics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS